Anoïsia Courtois
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anoïsia Courtois has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Damien Esparteiro
GRAP INSERM U1247, Curs Université Picardie Jules Verne Amiens France
1 shared publication - Eric Nguyen-Khac
GRAP INSERM U1247, Curs Université Picardie Jules Verne Amiens France
1 shared publication - Grégory Fouquet
GRAP INSERM U1247, Curs Université Picardie Jules Verne Amiens France
1 shared publication - Ingrid Marcq
Groupe de Recherche Sur L'Alcool Et Les Pharmacodépendances (GRAP), UMR 1247, INSERM, Centre Universitaire de Recherche en Santé (CURS) CHU Sud, Université de Picardie Jules Verne, Avenue de Conty, 80000, Salouel, Amiens, France.
1 shared publication Sophie Gérard
GRAP INSERM U1247, Curs Université Picardie Jules Verne Amiens France
1 shared publication
Latest Publications
- Open Access
- 16 January 2025
- Published by Wiley in Cancer Medicine
- Vol. 14 (2) , e70524
An Overview of In Vitro Models of Alcohol‐Related Hepatocellular Carcinoma
Background: Chronic and excessive alcohol consumption is the leading cause of death due to chronic liver disease. Alcohol‐related liver disease (ALD) encompasses a broad spectrum of clinical and pathological features, ranging from asymptomatic and reversible pathologies to hepatocellular carcinoma (HCC), a highly prevalent and deadly liver cancer. Indeed, alcohol consumption is one of the main worldwide etiologies of HCC. However, the impact of alcohol consumption on HCC pathophysiology and the associated mechanisms remains unclear. Thus, in vitro alcohol‐related HCC models are essential for addressing this issue and for assessing new molecular markers of this disease. In this review, we discuss the current in vitro models of alcohol‐related HCC. Our global overview demonstrates the lack of uniformity regarding HCC cell lines, alcohol concentration, and duration of alcohol exposure among existing models. Despite efforts to model alcohol exposure effectively that demonstrate enhancement of cancer cell transformation markers and HCC aggressiveness following, respectively, short‐term and long‐term alcohol exposure, current in vitro models possess numerous limitations.Aim: This review highlights future challenges in the development of more integrated and representative models of the complex pathophysiology of alcohol‐related HCC.
- 16 January 2025
- Published by Wiley in Cancer Medicine
- Vol. 14 (2) , e70524
Open AccessAn Overview of In Vitro Models of Alcohol‐Related Hepatocellular Carcinoma
Background: Chronic and excessive alcohol consumption is the leading cause of death due to chronic liver disease. Alcohol‐related liver disease (ALD) encompasses a broad spectrum of clinical and pathological features, ranging from asymptomatic and reversible pathologies to hepatocellular carcinoma (HCC), a highly prevalent and deadly liver cancer. Indeed, alcohol consumption is one of the main worldwide etiologies of HCC. However, the impact of alcohol consumption on HCC pathophysiology and the associated mechanisms remains unclear. Thus, in vitro alcohol‐related HCC models are essential for addressing this issue and for assessing new molecular markers of this disease. In this review, we discuss the current in vitro models of alcohol‐related HCC. Our global overview demonstrates the lack of uniformity regarding HCC cell lines, alcohol concentration, and duration of alcohol exposure among existing models. Despite efforts to model alcohol exposure effectively that demonstrate enhancement of cancer cell transformation markers and HCC aggressiveness following, respectively, short‐term and long‐term alcohol exposure, current in vitro models possess numerous limitations.Aim: This review highlights future challenges in the development of more integrated and representative models of the complex pathophysiology of alcohol‐related HCC.